medigraphic.com

2017, Number 3

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2017; 55 (3)

Neisseria meningitidis: A clinical case with multiorgan affection

Medina-Reyes A, Díaz-Polanco B, Sandoval-Chávez D, Nodal-Hernández M, Ayala-Franco JR

Language: Spanish
References: 20
Page: 388-393
PDF size: 354.37 Kb.


ABSTRACT

Neisseria meningitidis (Nm) is an agent feared for decades in the medical field due to its important morbidity and mortality. Ironically between 10 and 15% of the population will be asymptomatic carriers of this germ, which will also be ready to activate and manifest itself as a sickness at the right moment. We present the case of a nine-year-old girl who arrived at the Pediatric Emergency Service (to the Hospital General Region number 35, in Ciudad Juárez, Chihuahua) with the disease in multiple organs, where the Nm was isolated in the cerebrospinal fluid and in skin injuries, displaying three serotypes of Nm. Until today this germ still displays sensibility to penicillin use. Luckily the patient is still alive and without any neurological damage.


REFERENCES

  1. Centers for Disease Control and Prevention (CDC). Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report. 2005:54 (No. RR-7):1-21.

  2. Instituto Nacional de Estudios Históricos de las Revoluciones de México (INEHRM Salud). Brote de meningitis por N. Meningitidis en el Distrito Federal. Alerta epidemiológica. México, Distrito Federal: INEHRM Salud; 2010. Disponible en http://conapeme. org/version6/info/pediatras/Comunicados/alerta_ meningitis_230810.pdf

  3. Neisseria Meningitidis. External quality assessment scheme European Centre for Disease Prevention and Control. 2011. www.ecdc.europa.eu.

  4. Acosta-Merlano RE, Robín-Alonso RA. Neumonía por Neisseria meningitidis: reporte de un caso y revisión de la literatura. Rev Colomb Neumol. 2010; 22 (2): 33-36.

  5. Texereau M, Roblot P, Dumars A, Grignon B, Becq- Giraudon B. The usefulness of skin culture in the diagnosis of chronic meningococcemia. J Intern Med. 1997 Dec;242(6):519-20.

  6. Adams EM, Hustead S, Rubin P, Wagner R, Gewurz A, Graziano FM. Absence of the seventh component of complement in a patient with chronic meningococcemia presenting as vasculitis. Ann Intern Med. 1983 Jul;99(1):35-8.

  7. Organización Mundial de la Salud. Meningitis meningocócica. Nota descriptiva.Noviembre de 2012. Disponible en www.who.int/mediacentre/factsheets/fs141/es/

  8. Martínez JV, Verbanaz SC, Jordán R, Enríquez N, Efron ED. Meningococcemia Crónica. Servicio de Infectología. Hospital Británico, Buenos Aires, Argentina. 2008; 68: 298-300.

  9. Groves-Pinett M, Abdelnour A, Soley C, Arguedas- Mohs A. Enfermedad meningocócica: epidemiología, diagnóstico y vacunación. Acta méd. Costarric. 2013; 55: 8–17.

  10. Fajardo M, Maranon Y, Muñoz L, Zarallo L, Fernandez MJ. Infección por Neisseria Meningitidis: Presentación clínica atípica. Acta Pediátrica Portuguesa. 2006; 3,37: 104-106.

  11. Division of Disease Control. Department of Health, North Dakota. What Do I Need to Know? Meningococcal Meningitis. 2011. Disponible en: www.ndhealth. gov/disease

  12. Division of Disease Control. Update recommendations for use of meningococcal conjugate vaccine advisory committee on immunization practices (ACIP). MMWR. 2011; 60 (No.3): 72-6.

  13. Gasparini R, Amicizia D, Lai PL, Panatto D. Neisseria meningitidis, pathogenetic mechanisms to overcome the human immune defences. J Prev Med Hyg. 2012 Jun;53(2):50-5.

  14. Couto-Alves Alexessander, Couto-Alves. A new scoring system derived from base excess and platelet count at presentation predicts mortality in pediatric meningococcal sepsis. Critical Care 2013, 17:R68. http://ccforum.com/content/17/2/R68.

  15. Sevilla E, Ramírez JM, Villarreal L, Mata E, Trujillo JN. meningitidis. Informe de un caso de meningitis complicado con artritis séptica. Rev Mex Patol Clin. 2007; Vol. 54, 2, 83-91.

  16. Instituto de Salud Pública de Chile. Vigilancia de Laboratorio de enfermedad invasora Neisseria meningitidis. Laboratorio de Referencia 2006-2011. Instituto de Salud. Santiago, Chile: ISPCH; marzo de 2012. Disponible en http://www.ispch.cl/sites/default/files/ Bolet%C3%ADn%20Neisseria%20Meningitidis%20 26%20marzo.pdf

  17. Zalmanovici-Trestoreanu A, Fraser A, Gafter-Gvili A, Paul M, Leibovici L. Antibióticos para la prevención de infecciones meningocócicas. Cochrane Database Syst Rev. 2013; N° 10: 1–58.

  18. Knuf M, Romain O, Kindler K, Walther U, Tran PM, Pankow-Culot H, et al. Immunogenicity and safety of the quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) in 2–10-year-old children: results of an open, randomised, controlled study. Eur J Pediatr. 2013 May;172(5):601-12.

  19. THE AMERICAN ACADEMY OF PEDIATRICS. Udated Recommendations on the Use of Meningococcal Vaccines. COMMITTEE ON INFECTIOUS DISEASES. July 2014. 134: 400–403.

  20. Panatto D, Amicizia. New versus old meningococcal Group B vaccines: How the new ones may benefit infants & toddlers. Department of Health Sciences, University of Genoa, Genoa, Italy. Department of Health Sciences, University of Genoa, via Pastore. 2013. 1-16132, Genoa, Italy.




2020     |     www.medigraphic.com